Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 5Obesity 5Sexual Infantilism 4Craniopharyngioma 3Overweight 2Weight Loss 1Pancreatic Neoplasms 1Insulin Resistance 1Fatty Liver 1Diabetes Mellitus, Type 2 1Diabetes Mellitus, Type 1 1

Interventions

otelixizumab 1Waist-Hip Ratio 1Waist Circumference 1Time 1Islets of Langerhans Transplantation 1Insulin 1High-Intensity Interval Training 1Exenatide 1Etanercept 1Echocardiography 1Cardiovascular Physiological Phenomena 1Body Mass Index 1Body Composition 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Diabetes Mellitus, Type 1 × Exenatide × Clear all
NCT00566813 2021-04-06

Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression

University of Illinois at Chicago

Phase 1/2 Completed
10 enrolled 10 charts

Diabetes Mellitus, Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡